Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity
Understanding the major pathological pathways and the key molecules involved in the pathogenesis of inflammatory processes in joints, particularly in osteoarthritis (OA), is crucial for drug and pharmaconutraceuticals development. OA is a degenerative joint disease that predominantly affects articul...
Saved in:
| Main Authors: | O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2023-08-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/2067 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evidence base of pharmaconutraceuticals with chondroprotective action
by: O. A. Shavlovskaya, et al.
Published: (2024-04-01) -
Consistent use injectable and oral chondroprotectors in patients with osteoarthritis and lower back pain. Case report
by: Olga A. Shavlovskaya, et al.
Published: (2024-12-01) -
On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis
by: I. V. Sarvilina, et al.
Published: (2024-08-01) -
Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views
by: O. A. Shavlovskaya, et al.
Published: (2022-08-01) -
Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01)